Page last updated: 2024-09-03

forasartan and angiotensin ii

forasartan has been researched along with angiotensin ii in 10 studies

Compound Research Comparison

Studies
(forasartan)
Trials
(forasartan)
Recent Studies (post-2010)
(forasartan)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
151038,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomyforasartan (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anzini, M; Cappelli, A; De Benedetti, PG; Ferrari, F; Gallelli, A; Giorgi, G; Makovec, F; Mennuni, L; Menziani, MC; Pericot Mohr Gl, Gl; Rizzo, M; Vomero, S1
Bittner, SE; Brown, MA; Chen, ST; Corpus, VM; McGraw, DE; McMahon, EG; Null, CL; Olins, GM; Palomo, MA; Smits, GJ1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Takaori, K; Yukimura, T1
Furukawa, T; Usune, S1
Brunner, HR; Burns, TS; Hagmann, M; Karim, A; Naudin, RB; Nussberger, J; Waeber, B1
Babler, MA; Cook, CS; McMahon, EG; Olins, GM; Palomo, MA; Suleymanov, OD; Yang, PC1
Abe, Y; Aki, Y; Kimura, S; Kiyomoto, K; Nishiyama, A; Tomohiro, A1
Furukawa, T; Katsuragi, T; Kushiku, K; Shibata, K; Tokunaga, R; Yamada, H1
Guangyuan, L; Honda, K; Katsuragi, T; Sato, C1
Krovat, EM; Langer, T1

Trials

1 trial(s) available for forasartan and angiotensin ii

ArticleYear
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
    Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:4

    Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Area Under Curve; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Injections, Intravenous; Male; Pyridines; Radioimmunoassay; Renin; Single-Blind Method; Tetrazoles; Vasoconstrictor Agents

1997

Other Studies

9 other study(ies) available for forasartan and angiotensin ii

ArticleYear
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Journal of medicinal chemistry, 2004, May-06, Volume: 47, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Computer Simulation; Crystallography, X-Ray; Drug Design; Imidazoles; In Vitro Techniques; Isometric Contraction; Ligands; Liver; Male; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Purines; Pyridines; Quinolines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrazoles

2004
Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:4

    Topics: Administration, Oral; Adrenal Cortex; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Blood Pressure; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle, Smooth; Peptidyl-Dipeptidase A; Pyridines; Rabbits; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin; Tetrazoles; Uterus

1993
Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats.
    European journal of pharmacology, 1994, Sep-15, Volume: 269, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blotting, Northern; Captopril; Collagen; Extracellular Matrix; Gene Expression Regulation; Heart Ventricles; Hypertension; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta

1994
Effects of SC-52458, a new nonpeptide angiotensin II receptor antagonist, on increase in cytoplasmic Ca2+ concentrations and contraction induced by angiotensin II and K(+)-depolarization in guinea-pig taenia coli.
    General pharmacology, 1996, Volume: 27, Issue:7

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atropine; Calcium; Colon; Cytoplasm; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuromuscular Depolarizing Agents; Parasympatholytics; Potassium; Pyridines; Tetrazoles; Tetrodotoxin

1996
Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    American journal of hypertension, 1997, Volume: 10, Issue:6

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Hypertension, Renovascular; Pyridines; Rabbits; Rats; Tetrazoles

1997
The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1997, Volume: 20, Issue:4

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine; Dogs; Enzyme Inhibitors; Female; Kidney; Male; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phenylephrine; Pyridines; Renal Artery; Renal Circulation; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

1997
Upregulation of immunoreactive angiotensin II release and angiotensinogen mRNA expression by high-frequency preganglionic stimulation at the canine cardiac sympathetic ganglia.
    Circulation research, 2001, Jan-19, Volume: 88, Issue:1

    Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Atropine; Blotting, Northern; Captopril; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Ganglia, Sympathetic; Gene Expression Regulation; Heart; Heart Rate; Pentolinium Tartrate; Pyridines; RNA, Messenger; Stellate Ganglion; Tetrazoles; Tissue Distribution; Up-Regulation

2001
Inositol(1,4,5)trisphosphate signal triggers a receptor-mediated ATP release.
    Biochemical and biophysical research communications, 2002, May-03, Volume: 293, Issue:2

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcium Channels; Calcium Signaling; Cell Line; Cells, Cultured; Colon; Guinea Pigs; Humans; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Muscle, Smooth; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Tetrazoles

2002
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Journal of medicinal chemistry, 2003, Feb-27, Volume: 46, Issue:5

    Topics: Acrylates; Algorithms; Angiotensin II; Biphenyl Compounds; Databases, Factual; Imidazoles; Lactones; Losartan; Models, Molecular; Molecular Conformation; Pyridines; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfones; Tetrazoles; Thiophenes

2003